Literature DB >> 16339305

Human cancers overexpress genes that are specific to a variety of normal human tissues.

Joseph Lotem1, Dvir Netanely, Eytan Domany, Leo Sachs.   

Abstract

We have analyzed gene expression data from three different kinds of samples: normal human tissues, human cancer cell lines, and leukemic cells from lymphoid and myeloid leukemia pediatric patients. We have searched for genes that are overexpressed in human cancer and also show specific patterns of tissue-dependent expression in normal tissues. Using the expression data of the normal tissues, we identified 4,346 genes with a high variability of expression and clustered these genes according to their relative expression level. Of 91 stable clusters obtained, 24 clusters included genes preferentially expressed either only in hematopoietic tissues or in hematopoietic and one to two other tissues; 28 clusters included genes preferentially expressed in various nonhematopoietic tissues such as neuronal, testis, liver, kidney, muscle, lung, pancreas, and placenta. Analysis of the expression levels of these two groups of genes in the human cancer cell lines and leukemias identified genes that were highly expressed in cancer cells but not in their normal counterparts and, thus, were overexpressed in the cancers. The different cancer cell lines and leukemias varied in the number and identity of these overexpressed genes. The results indicate that many genes that are overexpressed in human cancer cells are specific to a variety of normal tissues, including normal tissues other than those from which the cancer originated. It is suggested that this general property of cancer cells plays a major role in determining the behavior of the cancers, including their metastatic potential.

Entities:  

Mesh:

Year:  2005        PMID: 16339305      PMCID: PMC1317977          DOI: 10.1073/pnas.0509360102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Superparamagnetic clustering of data.

Authors: 
Journal:  Phys Rev Lett       Date:  1996-04-29       Impact factor: 9.161

Review 2.  E2A basic helix-loop-helix transcription factors in human leukemia.

Authors:  David P LeBrun
Journal:  Front Biosci       Date:  2003-05-01

3.  Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis.

Authors:  Koichi Akashi; Xi He; Jie Chen; Hiromi Iwasaki; Chao Niu; Brooke Steenhard; Jiwang Zhang; Jeff Haug; Linheng Li
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

4.  Robust estimators for expression analysis.

Authors:  Earl Hubbell; Wei-Min Liu; Rui Mei
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

5.  Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis.

Authors:  Jun-ichi Okutsu; Tatsuhiko Tsunoda; Yasuyuki Kaneta; Toyomasa Katagiri; Osamu Kitahara; Hitoshi Zembutsu; Rempei Yanagawa; Shuichi Miyawaki; Kazutaka Kuriyama; Nobuyuki Kubota; Yukihiro Kimura; Kohmei Kubo; Fumiharu Yagasaki; Toshio Higa; Hirokuni Taguchi; Tadasu Tobita; Hideki Akiyama; Akihiro Takeshita; Yan-Hua Wang; Toshiko Motoji; Ryuzo Ohno; Yusuke Nakamura
Journal:  Mol Cancer Ther       Date:  2002-10       Impact factor: 6.261

6.  Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.

Authors:  Barbara Jarzab; Malgorzata Wiench; Krzysztof Fujarewicz; Krzysztof Simek; Michal Jarzab; Malgorzata Oczko-Wojciechowska; Jan Wloch; Agnieszka Czarniecka; Ewa Chmielik; Dariusz Lange; Agnieszka Pawlaczek; Sylwia Szpak; Elzbieta Gubala; Andrzej Swierniak
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

7.  Induction in myeloid leukemic cells of genes that are expressed in different normal tissues.

Authors:  Joseph Lotem; Hila Benjamin; Dvir Netanely; Eytan Domany; Leo Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 8.  DNA methylation, chromatin inheritance, and cancer.

Authors:  M R Rountree; K E Bachman; J G Herman; S B Baylin
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

9.  Gene expression profiling of pediatric acute myelogenous leukemia.

Authors:  Mary E Ross; Rami Mahfouz; Mihaela Onciu; Hsi-Che Liu; Xiaodong Zhou; Guangchun Song; Sheila A Shurtleff; Stanley Pounds; Cheng Cheng; Jing Ma; Raul C Ribeiro; Jeffrey E Rubnitz; Kevin Girtman; W Kent Williams; Susana C Raimondi; Der-Cherng Liang; Lee-Yung Shih; Ching-Hon Pui; James R Downing
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

10.  Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.

Authors:  C H Pui; H H Mahmoud; G K Rivera; M L Hancock; J T Sandlund; F G Behm; D R Head; M V Relling; R C Ribeiro; J E Rubnitz; L E Kun; W E Evans
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

View more
  10 in total

1.  Bayesian Framework for Detecting Gene Expression Outliers in Individual Samples.

Authors:  John Vivian; Jordan M Eizenga; Holly C Beale; Olena M Vaske; Benedict Paten
Journal:  JCO Clin Cancer Inform       Date:  2020-02

2.  Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.

Authors:  Anna Andersson; Patrik Edén; Tor Olofsson; Thoas Fioretos
Journal:  BMC Med Genomics       Date:  2010-03-08       Impact factor: 3.063

3.  Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles.

Authors:  Jacob Bock Axelsen; Jacob Bock-Axelsen; Joseph Lotem; Leo Sachs; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

4.  Receptor-Independent Ectopic Activity of Prolactin Predicts Aggressive Lung Tumors and Indicates HDACi-Based Therapeutic Strategies.

Authors:  Aurore Le Bescont; Anne-Laure Vitte; Alexandra Debernardi; Sandrine Curtet; Thierry Buchou; Jessica Vayr; Aurélien de Reyniès; Akihiro Ito; Philippe Guardiola; Christian Brambilla; Minoru Yoshida; Elisabeth Brambilla; Sophie Rousseaux; Saadi Khochbin
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

5.  The network organization of cancer-associated protein complexes in human tissues.

Authors:  Jing Zhao; Sang Hoon Lee; Mikael Huss; Petter Holme
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

6.  Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.

Authors:  K Rohini; J Mathivanan; P D Antony Herold Prabhu; D K Subbakrishna; M L Gope; B A Chandramouli; S Sampath; B Anandh; R Gope
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

7.  Heterogeneity of transcription factor binding specificity models within and across cell lines.

Authors:  Mahfuza Sharmin; Héctor Corrada Bravo; Sridhar Hannenhalli
Journal:  Genome Res       Date:  2016-06-16       Impact factor: 9.043

8.  Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.

Authors:  Tali Eilon; Itamar Barash
Journal:  BMC Cancer       Date:  2008-09-24       Impact factor: 4.430

Review 9.  Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence".

Authors:  M Tarabichi; A Antoniou; M Saiselet; J M Pita; G Andry; J E Dumont; V Detours; C Maenhaut
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

10.  Differential expression of the metastasis suppressor KAI1 in decidual cells and trophoblast giant cells at the feto-maternal interface.

Authors:  Tae Bon Koo; Min-Su Han; Yamashita Tadashi; Won Joon Seong; Je-Yong Choi
Journal:  BMB Rep       Date:  2013-10       Impact factor: 4.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.